In the irinotecan and cisplatin group , median overall survival was @ years ( @ % CI @-@ @ ) ; overall survival did not differ between the two groups ( hazard ratio @ -LSB- @ % CI @-@ @ -RSB- , one-sided stratified log-rank p = @ ) .